Originally published In Press as doi:10.1074/jbc.M001245200 on April 12, 2000
J. Biol. Chem., Vol. 275, Issue 25, 19018-19024, June 23, 2000
First Apyrase Splice Variants Have Different Enzymatic
Properties*
Annette
Biederbick
§,
Christian
Kosan§¶,
Jürgen
Kunz¶, and
Hans-Peter
Elsässer
From the
Institut für Klinische Zytobiologie
und Zytopathologie, Philipps-Universität Marburg, Robert-Koch
Strasse 5, D-35033 Marburg, Germany and the ¶ Zentrum für
Humangenetik, Institut für Allgemeine Humangenetik,
Philipps-Universität Marburg, Bahnhofstrasse 7, D-35033
Marburg, Germany
Received for publication, February 15, 2000, and in revised form, April 15, 2000
 |
ABSTRACT |
LALP70 is a novel lysosomal membrane protein
belonging to the apyrase protein family. The apyrase protein family
comprises enzymes capable of cleaving nucleotide tri- and diphosphates
in a calcium- or magnesium-dependent manner, not being
altered by P-type, F-type, or V-type NTPase inhibitors. In this study
we have cloned and sequenced the human LALP70 gene to
determine the genomic structure. The gene is organized in 11 introns
and 12 exons covering a genomic region of approximately 16 kilobase
pairs. By fluorescence in situ hybridization analysis, the
hLALP70 gene was mapped to the human chromosome
8p21.1-p21.3. We further show that there is at least one alternatively
spliced variant, hLALP70v, which can be generated via an alternative
splice side at the 3'-end of exon 7, leading to a protein variant
differing in 8 amino acids (VSFASSQQ). This is the first splice variant
that has been described in the apyrase protein family. Reverse
transcriptase polymerase chain reaction analysis showed an ubiquitous
expression of both variants, with different relative mRNA
expression levels in different tissues. Comparison of the enzymatic
properties of the splice variants revealed a broader substrate
specificity for hLALP70v with CTP, UDP, CDP, GTP, and GDP as preferred
substrates, while hLALP70 utilized UTP and TTP preferentially.
Furthermore, enzyme activity of hLALP70v was equally dependent on
Ca2+ and Mg2+, being saturated already at 1 mM concentration. In contrast, hLALP70 enzymatic activity
were unsaturated up to 10 mM Ca2+, while
Mg2+ showed a saturation at already 1 mM
concentration with 2-3-fold lower enzymatic activity as observed with
Ca2+. Our data suggest that the presence or absence of the
8-amino acid motif VSFASSQQ provoke differences in substrate
specificity and divalent cation dependence of hLALP70/hLALP70v.
 |
INTRODUCTION |
The apyrase protein family comprises enzymes capable of cleaving
nucleotide tri- and diphosphates in a calcium- or
magnesiumdependent manner, not being altered by P-type, F-type,
or V-type NTPase inhibitors (1). Members of the apyrase family contain
up to four homolog conserved sequence stretches, which have been
described as apyrase conserved regions
(ACRs1; Ref. 2). The
substrate specificity differs between different apyrases and seems to
be sensitive to small changes in the amino acid sequence outside the
ACRs. This was shown for the 97% identical apyrase isoforms (NTP1 and
NTP3) of Toxoplasma gondii (3, 4) and in human brain E-type
apyrase after side-directed mutagenesis of two conserved tryptophan
residues (5). Apyrases with a substrate specificity restricted to
nucleotide triphosphates are classified as E-type ATPases (1, 6).
Originally, apyrases have been described as ectoenzymes, like CD 39 (7), or other ecto NTPases (1, 6, 8). However, meanwhile several
apyrases have been localized intracellularly (2, 3, 9-11).
The human lysomal apyrase-like protein (hLALP70) belongs to the apyrase
gene family, based on four ACRs in the N-terminal half of the sequence
(11). The hLALP70 cDNA has an open reading frame of 1848 bp,
encoding a protein with a molecular mass of 71 kDa (11). Based on
sequence analysis, hydrophobicity plot and in vitro
transcription/translation studies, hLALP70 is thought to be inserted in
the membrane as a type III membrane protein (11, 12), with one
transmembrane domain at the C terminus and two transmembrane domains at
the N terminus of the protein. The amino acid sequence of hLALP70 is
nearly identical with the sequence of the human UDPase (hUDPase; Ref.
10), except for an additional stretch of 8 amino acids, located 7 amino
acids downstream from the ACR4 in the hLALP70 protein. We have isolated and analyzed the hLALP70 gene and provide evidence that the
hUDPase is a splice variant of hLALP70. This is the first splice
variant described so far for the apyrase family. RT-PCR analysis
revealed a differential expression of hLALP70 and its splice variant.
Finally we show that the two proteins differing in the 8 amino acids
exhibit differences in their enzymatic properties.
 |
EXPERIMENTAL PROCEDURES |
Cloning and Analyzing of the Human LALP70 Gene--
For
isolation of genomic clones containing the human LALP70
gene, high density PAC hybridization filters (RLDB2, Berlin, Germany) were used. As probe a 321-bp fragment of the hLALP70 gene, representing the 3'-portion of the cDNA sequence (GenBankTM
accession number AJ131358), was amplified by PCR using primers (LALP1f,
5'-CGG GGC GTT TCC TTT GTCTAC-3' and LALP1r, 5'-CTC GGC CTG CAT TTT GTT
TTT-3', annealing temperature: 58 °C). After hybridization a strong
signal for PAC131C11, and weaker signals for several additional clones,
were observed. PAC131C11 was used for the determination of the genomic
structure by sequencing.
Sequencing templates were generated by means of PCR using
cDNA-derived primers. PCR products were separated by gel
electrophoresis and purified using the QIAquick PCR Purification Kit
(Qiagen). Approximately 75 ng of purified DNA was used for cycle
sequencing. The cycle sequencing was performed according to
manufacture's recommendations using ABI Prism BigDye terminator kit
(PE Biosystems). Products from cycle sequencing were concentrated using
standard ethanol precipitation procedure and analyzed on a ABI 373 automated sequencer (Applied Biosystems). The resulting sequences were
aligned by the software package Sequencher (Gene Codes, Ann Arbor, MI).
To confirm that LALP70 and LALP70v (see below) are transcripts from the
same gene, we performed a PCR analysis using primers LALP2f/r and
LALP3f/r (Fig. 3A; LALP2f, 5'-ATGGGCGGCGTGTCGACT-3'; LALP2r,
5'-TTAGAGGGAAGTCTGGGTCTC-3'; LALP3f, 5'-TGATGTTCACCAAACTGAGC-3'; LALP3r, 5'-AGGTCAAAGTCTCCAGTCCC-3'; annealing temperature 55 °C). As
template we used either genomic DNA obtained from six unrelated individuals or the PAC131C11 DNA, respectively. Southern blot analysis
was performed according to standard protocols. As hybridization probe
we used a 400-bp PCR product generated with the LALP2f/r primers from
the LALP70 cDNA as template. LALP2f/r primers are identical to
those used by Wang and Guidotti (10).
Chromosomal Localization--
The chromosomal localization of
human LALP70 gene by fluorescence in situ
hybridization (FISH) analysis was carried out on spreads of human
lymphocyte metaphase chromosomes, with biotinylated PAC131C11 DNA as
probe as described previously (13). In brief, 30 ng of total PAC DNA
was labeled with biotin-7-dATP by nick translation (Nick Translation
Kit, Life Technologies, Inc.) and detected after hybridization
procedure with FITC streptavidin, biotinylated goat anti-streptavidin,
and FITC streptavidin (Vector Laboratories, Burlingame, CA). Chromosome
counterstaining was performed using DAPI, and slides were embedded in
Vectashield (Vector). The preparations were analyzed with a Zeiss
epifluorescence microscope, equipped with a CCD camera (Photometrics,
München, Germany) controlled by the software package Smartcapture
(Vysis, Bergisch-Gladbach, Germany).
Radiation Hybrid Panel Screen--
Additional to FISH
localization, hLALP70 was mapped with the Genebridge 4 radiation hybrid panel consisting 93 radiation hybrid clones of the
human genome (Research Genetics). Screen were performed in duplicate,
and the results of the PCR analysis were submitted to the server at the
Whitehead Institute/MIT Center for Genome Research's radiation hybrid
map of the human genome.
RT-PCR Analysis--
For the isolation of total RNA samples from
different organs indicated in Fig. 3 were snap-frozen in liquid
nitrogen and stored at
80 °C. Tissue samples were extracted with
RNAclean (AGS) according to the manufacturer's instructions. 6 µg
were used for the RT reaction in a total volume of 20 µl. As primer
the lower primer indicated in Fig. 4A was used (20 pmol).
Reverse transcription was performed for 2 h at 42 °C with 10 units of a reverse transcriptase from avian myeloblastosis virus
(U. S. Biochemical Corp.). 5 µl from the RT reaction mix was used
for a subsequent PCR in a total volume of 50 µl using 20 pmol of each
primer indicated in Fig. 3 and 10 units of Taq polymerase
(Promega). The annealing temperature was set to 56 °C and the PCR
was run for 35 cycles. 20 µl of the PCR reaction mix were analyzed on
a 3% Metaphor-agarose gel (FMC Bioproducts) in TBE buffer (90 mM Tris base, 10 mM boric acid, 2 mM EDTA).
Cloning of Expression Vectors--
The full-length hLALP70
cDNA plus 105 bp 5'- and approximately 350 bp 3'-untranslated
regions was subcloned into the pMCS-5 vector (MoBiTec, Göttingen,
Germany) using FseI and XhoI restriction sites
after a complete digest with FseI and a partial digest with XhoI. The hLALP70v cDNA was generated from the
hLALP70-pMCS plasmid by deletion of the 24 bp between nucleotides
1028-1051 by PCR amplification using the Quick Change Site-Directed
Mutagenesis kit from Stratagene. The sense deletion primer 5'-GCG TAC
GAA GTC CCC AAA ACT GAA GAA GTA GCT-3' was complementary to the
antisense deletion primer 5'-AGC TAC TTC TTC AGT TTT GGG GAC TTC GTA
CGC-3'. The deletion mutagenesis was performed according to the
manufacturer's instruction. The amplified cDNA was provided in
Escherichia coli XL1-blue supercompetent cells (Stratagene).
The correctness of the 24-bp deletion was confirmed by DNA sequencing.
Both hLALP70 and hLALP70v were cloned into the mammalian expression
vector pCL-Neo (Promega) using MluI and XbaI
restriction sites.
Cell Culture and Transfection--
COS-7 cells were cultivated
in Dulbecco's modified Eagle's medium supplemented with 2 g/liter
Hepes, 5% fetal calf serum, 5% adult calf serum, 50 µg/ml
gentamycin, and incubated at 37 °C in a humidified chamber
equilibrated with 5% CO2. COS-7 cells were transfected
with the mammalian pCL-Neo expression vector alone or with this vector
containing either the cDNA for hLALP70 or for hLALP70v,
respectively, using a 25-kDa polyethyleneimine (Aldrich) as
transfection reagent. Transfection procedure was performed as described
elsewhere (Biederbick et al. (11)). Transfected cells were
harvested for the apyrase enzymatic assay 24 h after transfection.
Preparation of COS Cell Crude Membranes--
Transfected COS-7
cells were homogenized with a Dounce homogenizer, and nuclei were
separated as described elsewhere (14). To separate the crude membrane
fraction from the cytosol the postnuclear supernatant were centrifuged
with 105,000 × g. The pellets were resuspended in 400 µl of 20 mM Hepes, pH 7.4, 120 mM NaCl, 5 mM KCl, 0.2 mM EDTA containing 0.1% Triton
X-100. The protein concentration in each sample was determined with
bicinchoninic acid (Sigma) according to the manufacture's instructions.
Measurement of Nucleotide Phosphatase Activity--
To measure
apyrase activity COS-7 membrane suspension containing 6 µg total
protein were adjusted to 45 µl with reaction buffer containing 20 mM Hepes, pH 7.4, 120 mM NaCl, 5 mM
KCl, 0.2 mM EDTA, 1 mM NaN3, and
0.5 mM Na3VO4, with or without 5 mM CaCl2. After preincubation of 5 min at
37 °C nucleotide phosphatase reactions were initiated by the
addition of 5 µl of the same buffer containing 10 mM
nucleotide phosphate substrates to give a final concentration of 1 mM. Samples were incubated for 20 min at 37 °C. NTP/NDP
hydrolysis under these conditions were linear up to 30 min. Apyrase
activity was determined by measuring the inorganic phosphate released
as described previously (15, 16). Values obtained from samples without
CaCl2 or MgCl2 were subtracted from those
obtained with CaCl2 or MgCl2. All measurements
were done in triplicate.
 |
RESULTS |
Cloning, Sequencing, and Mapping of the hLALP70 Gene--
Primers
specific for the human LALP70 gene identified a PAC clone (131C11) with
a 80-kb insert (data not shown). This PAC clone was subsequently used
for primer-directed sequence walk to analyze the genomic structure of
the human LALP70 gene. Our sequence analysis of the
hLALP70 gene revealed that it contains 12 exons and 11 introns, covering a genomic region of approximately 16 kb (Fig.
1A; Table
I). The sizes of the exons range from 8 nucleotides (exon 1) to 325 bp (exon 9). Sequence analysis of the
intron-exon junctions revealed that all splice sites obeyed the GT-AG
paradigm (Table I). The hLALP70 gene containing PAC131C11 clone was found to hybridize specifically at a single locus on the
short arm of chromosome 8 (Fig.
2A), and no specific signals were observed on any other chromosome. DAPI banding analysis indicated the localization of hLALP70 to the chromosomal region
8p21.1-p21.3 (Fig. 2B). To map the gene more precisely, we
used for radiation hybrid mapping the Genbridge G4 panel (Research
Genetics, Huntsville, AL) and PCR. Primers for mapping were described
above. We determined that the gene is located 0.4 centiRay distal to
WI-961 (LOD >3.1), which is located in the Genethon map between the
markers D8S1734 and D8S1820 (44.9 and 54.2 centimorgans from the top of
chromosome 8, respectively). In this area the EST sequence KIAA0392,
which represents the 3'-end of the hLALP70v cDNA
(GenBankTM accession number AF016032), has been located
previously (17).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Intron-exon organization of the human apyrase
like protein of 70-kDa gene (LALP70).
A, domain structure of the gene that comprises about 16 kb
and consists of 12 exons. The transmembrane domains and the ACRs I-IV
are indicated. The size of introns and exons are shown in Table I. The
corresponding GenBankTM accession number is AJ246165.
B, part of exon 7 illustrating the alternative splice sites
used to generate either hLALP70 or hLALP70v, respectively.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Sizes and junctions of the exons and introns of the human LALP70
gene
Intron sequences are given in small characters and exon sequences in
capital characters.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Chromosomal localization of
LALP70. A, to locate LALP70
FISH analysis on metaphase chromosomes was perfomed using 30 ng of
biotinylated PAC131C11 DNA as a probe. FITC streptavidin was used as
detection reagent. LALP70 could be attributed to the short
arm of chromosome 8 (arrows). B, using the DAPI
counterstain technique LALP70 could be located to
8p21.1-p21.3 region.
|
|
hLALP70 is almost identical to a Golgi apyrase (10) except for an
additional 24-base pair insert in the hLALP70 sequence. We located
these 24 bp at the end of exon 7. The 5'-end of the 24-bp stretch
provided an alternative splice site (Fig. 1B). Based on this
we concluded that the human Golgi apyrase might be a splice variant of
hLALP70, further designated as hLALP70v. In the paper published by Wang
and Guidotti (10) the authors used a genomic Southern blot approach
with EcoRI- or NdeI-digested genomic DNA and a
400-bp fragment from the hUDPase cDNA as hybridization probe, which
did not contain a EcoRI or NdeI restriction site.
Since they obtained two bands they speculated that there might be two similar genes. Correlation of the 400-bp fragment to the
LALP70 gene structure showed that the sequence contained the
entire exon 8, as well as parts of exon 7 and exon 9 (Fig.
3A). To confirm that hLALP70
and hLALP70v are transcripts from the same coding sequence, we used PCR
primers located in the 400-bp fragment used by Wang and Guidotti (Ref.
10; Fig. 3A, LALP3f/r). As template we used genomic DNA from
six unrelated individuals, all of which gave a single band of
approximately 2.9 kb (Fig. 3B, lanes 4-9, and
3C, lane 4), as expected from the LALP
gene structure (Table I and Fig. 3A). When the LALP cDNA
was used as template, a 320-bp fragment occurred (Fig. 3B,
lane 3). We performed the PCR also with the PAC131C11 DNA as
template and obtained the same 2.9-kb fragment (Fig. 3B,
lane 2, and 3C, lane 1). Digestion of
this fragment, or a fragment generated from genomic DNA (Fig.
3C, lanes 1 and 4) with either
EcoRI (Fig. 3C, lanes 2 and
5) or NdeI (Fig. 3C, lanes
3 and 6), resulted in two bands indicating one
restriction site for each enzyme within the 2.9-kb fragment. This was
confirmed by sequence analysis of the intron between exons 8 and 9, which contains one EcoRI and one NdeI restriction
site. Finally, we digested the PAC131C11 DNA with EcoRI or
NdeI, respectively, and performed a Southern blot analysis
using the 400-bp fragment as hybridization probe as described in Fig.
3. As shown in Fig. 3D we obtained the two expected bands
for each enzyme with an identical hybridization pattern as shown by
Wang and Guidotti (10). From these results we have to conclude that
hLALP70 and hLALP70v are transcripts from the same gene, generated by
alternative splicing.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Improvement of the one gene hypothesis for
hLALP70 and hLALP70v. A, part of the hLALP70
gene covering exon 7 to exon 9. Arrows indicate the location
of primer pairs used in the experiments shown in B and
C. LALP2f/r are identical to the primers used by Wang and
Guidotti (10) to generate a 400-bp fragment from the LALP70 cDNA,
which was used for hybridization in D. N,
NdeI restriction site; E, EcoRI
restriction site. B, LALP3f/r primers were used for PCR with
PAC131C11 DNA (lane 2), LALP70 cDNA (lane 3),
and genomic DNA from six unrelated human individuals (lanes
4-9). Lane 1, PCR without template. C,
LALP3f/r primers were used for PCR with PAC131C11 DNA (lane
1) and with human genomic DNA (lane 4), and the
fragments obtained were either cut with EcoRI (lanes
2 and 5) or NdeI (lanes 3 and
6). Note that bands in lane 3 and 6 are double bands, which were not resolved as single bands.
D, Southern blot analysis of the PAC131C11 DNA either
digested with EcoRI (lane 1) or NdeI
(lane 2) and hybridized with the probe described in
A).
|
|
Identification and Expression of a mLALP Splice Variant--
In
subsequent experiments we analyzed the expression of mLALP and mLALPv
in 14 different mouse tissues by a RT-PCR approach (Fig.
4A). Primers were designed
according to a mouse EST (GenBankTM accession number
AA497420) representing the hLALP70 mouse homolog (mLALP) containing the
24 bp (Fig. 4A). PCR primer were flanking the 24 bp. The
5'-sequence of the upper primer was complemented with a sequence from
the human LALP70, since only 11 bp of the 5'-upstream mLALP sequence
were available from the data base (Fig. 4A). Results from
the RT-PCR approach revealed that both mLALP and mLALPv were expressed
in all tissues (Fig. 4B). However, the relative level of
mLALPv was always much lower than that of mLALP. The highest expression
of mLALPv were found in liver and kidney (Fig. 4B). We
conclude that mLALP and mLALPv are both ubiquitously expressed, but
that the levels of expression might be tissue-specific.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
RT-PCR analysis of mLALP70 and mLALP70v
expression. A, alignment of the mouse EST homolog to
hLALP70. Underlined sequence in small letters
shows the 24 bp that are removed in the splice variant hLALP70v. Short
bold sequences represent the upper and lower primer,
respectively, which were used for RT-PCR. Note that the first 8 nucleotides of the upper primer were derived from the human sequence.
B, RT-PCR results obtained with total RNA from mouse organs
as indicated. While the 155-bp band represents mLALP, the 131-bp band
represents mLALPv.
|
|
Analysis of Substrate Specificity--
In our next experiment we
analyzed the enzyme substrate specificity of the human LALP70 and its
splice variant hLALP70v to determine the influence of the 8 amino acids
VSFASSQQ on the enzyme activity. Data from other apyrases have shown
that only slight differences in the sequence can have a marked
influence on the substrate specificity (4, 5, 18). Moreover, our own
experiments revealed that a green fluorescence protein tag also changed
the substrate specificity (data not shown). For this reason we cloned hLALP70 and hLALP70v into an expression vector without any tag. Using
lysates from cells that had been transfected with these constructs we
measured the apyrase activity for a variety of NTPs and NDPs as
indicated in Fig. 5. While hLALP70
exhibited the highest enzyme activity on UTP and TTP, hLALP70v cleaved
CTP most efficiently followed by CDP, UDP, and GTP. Thus, hLALP70v has
a broad substrate specificity indicative for a typical apyrase based on
a definition by enzymatic properties (1). According to these results,
hLALP70v does not represent a typical UDPase as has been published on
the basis of enzyme data obtained with a LALP70v/myc fusion protein (10).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 5.
Substrate specificity of hLALP70 and
hLALP70v. A crude membrane preparation from cells transfected
either with a hLALP70 cDNA, or a hLALP70v cDNA, or the vector
alone was used to measure the nucleoside phosphatase activity in the
presence of NaN3 and Na3VO4 as
described under "Experimental Procedures." Different NTP and NDP
substrates were used as indicated. The assay was performed in the
presence or absence of 5 mM Ca2+, and and the
data obtained with Ca2+ were corrected with the values
obtained without Ca2+. Mean values from three separate
measurements are given.
|
|
Analysis of Divalent Ion Dependence--
Since apyrase activity
usually depends on the presence of divalent cations, we compared
hLALP70 and hLALP70v activity under a concentration range of
Ca2+ and Mg2+, respectively. As substrate we
used UTP for hLALP70 and CTP for hLALP70v. hLALP70 enzymatic activity
showed a linear increase up to 10 mM concentrations of
Ca2+ (Fig. 6A). In
contrast, hLALP70 apyrase activity was already saturated at 1 mM Mg2+ (Fig. 6A). At 5 mM concentrations the enzyme activity was three to four
times higher with Ca2+ than with Mg2+. With
hLALP70v, a rapid increase of enzyme activity was observed up to 1 mM Ca2+ and Mg2+, comparable with
the kinetic observed for hLALP70v (Fig. 6B). However, total
enzyme activity of hLALP70v was 2-3-fold higher than of hLALP70 for
both Ca2+ and Mg2+. Enzyme activity was
saturated for Ca2+ and Mg2+ concentrations
higher than 1 mM (Fig. 6B). Thus, hLALP70v can use either Ca2+ or Mg2+ equally, while LALP70
shows a preference for Ca2+. We conclude, that hLALP70 and
hLALP70v have a different dependence on divalent cations based on
structural changes induced by the presence or absence of the 8 amino
acids VSFASSQQ.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Dependence of hLALP70 and hLALP70v on
divalent ions. Nucleoside phosphatase activity in crude membrane
preparations was measured as in the experiment described in the legend
to Fig. 4, but with different concentrations of Mg2+ or
Ca2+. A, LALP70 nucleoside phosphatase activity
in dependence on Ca2+ and Mg2+. B,
LALP70v nucleoside phosphatase activity in dependence on
Ca2+ and Mg2+.
|
|
 |
DISCUSSION |
The human apyrase LALP70 is identical to the human Golgi UDPase
(10), with the exception of additional 24 bp, which are located in the
central region of the LALP70 cDNA sequence (11). Comparison with
other apyrases showed that these 24 bp encoding the amino acids
VSFASSQQ are unique in the apyrase protein family (Fig.
7). A mouse EST (GenBankTM
accession number AA497420) highly homologous to the human LALP70 also
contained these 24 bp (Figs. 4A and 7) with only 2 conservative nucleotide exchanges. This indicates that the 8-amino acid
stretch has been conserved at least between mouse and man. Analysis of
the hLALP70 gene revealed that the 24 bp are located at the
end of exon 7. The 5'-junction of the 24 bp contains an alternative
splice site. However, Wang and Guidotti (10) performed a Southern blot
analysis from which they concluded that there might be another similar
gene copy in the genome in addition to their hUDPase gene.
They used EcoRI or NdeI for the digestion of
genomic DNA and a 400-bp fragment as a hybridization probe. They
assumed that this fragment, which did not contain a EcoRI or
NdeI site, was entirely located in one exon. Correlation of this 400-bp fragment to our estimated gene structure revealed that the
fragment covers the entire exon 8 and parts of exon 7 and exon 9. Our
results further show that there is a EcoRI and a
NdeI site in the intron between exon 8 and exon 9 (Fig.
3C and sequence data from the intron), suggesting that there
should be two bands Southern blot analysis after digestion of genomic
DNA with one of these enzymes and subsequent hybridization with the 400-bp fragment. This is the case in the paper of Wang and Guidotti (10) and also in the experiment shown in Fig. 3D where the
PAC clone DNA was used. The band size and pattern seen in Fig.
3D are identical with those described by Wang and Guidotti
(10), where the small EcoRI band results from the two
EcoRI sites indicated in Fig. 3A. Finally, PCR
analysis of six genomic human DNAs from unrelated individuals (Fig.
3B) further confirmed that there is only one gene copy in
the human genome for LALP70 and the hUDPase described by Wang and
Guidotti (10). Taken together, with the lack of any indication for more
than one gene for hLALP70 and the hUDPase, we conclude that the human
Golgi UDPase is a splice variant of hLALP70 (hLALP70v). hLALP70 and
hLALP70v are the first splice variants that have been described so far
in the apyrase protein family.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 7.
Partial alignment of hLALP70 and hLALP70v
with other apyrases. The partial alignment, focusing on the
sequence stretch containing the amino acid motif VSFASSQQ in LALP70,
shows that no other NTPase/NDPase belonging to the apyrase protein
family does contain this sequence. Accession numbers of the apyrases
indicated are: mCD39, NP_033978; rNTPase, AAC53195; hCD39, NP_001767;
bCD39, AAB62382; hCD39L3, NP_001239; hCD39L1, NP_001237; rATPase,
CAA72533; cATPase 1, AAC60071; mCD39L1, NP_033979; mUDPase,
CAB45533; Ara-NTPase 1, AAD39311; Ara-NTPase 3, AAD39310;
Ara-NTPase 2, AAC32915; hCD39L2, NP_001238; Drosophila,
AAC39133; CECD39, CAB05544; Ynd1p, NP_010920; GDA1p, NP_010872;
TgNTPase, AAC41569; Ara-NTPase 4, AAF00071; potato ATPase, P80595; Pea
NTPase, BAA89275; legume NTPase, AAD31285.
|
|
In preliminary RT-PCR experiments using primer flanking the 24-bp
sequence we observed a differential expression of hLALP70 and hLALP70v
in different human cell lines (data not shown). To investigate the
expression pattern of mLALP and mLALPv in different tissues, we
designed PCR primer flanking the 24 bp stretch in the mouse EST (Fig.
4A). Since only a few bases 5'-upstream of the 24-bp
sequence were given by the EST, we completed the upper primer sequence
from the adequate human sequence (Fig. 4A). The RT-PCR
results show that in all tissues analyzed, mLALP expression was
superior to the expression of mLALPv, but with variations in their
ratio (Fig. 4B). However, RNAs used for RT-PCR were from whole tissue samples containing a variety of different cell types. Thus, it cannot be excluded that in some cell types, which contribute only to a small percentage to a given tissue, the mLALP/mLALPv ratio is
inverted. Moreover, the turnover rates of the two proteins might be
different adjusting the protein amount of mLALP and mLALPv in the cell
to other levels as reflected by their relative amount of RNA. While our
data clearly show that both mLALP and mLALPv are expressed
ubiquitously, the detailed and cell-specific expression levels of these
two proteins have to be elucidated in further experiments on RNA and
protein level.
In initial experiments to measure the hLALP70 enzyme activity we used
hLALP70 and a hLALP70/green fluorescent protein (GFP) fusion protein.
We observed that the GFP had an influence on the substrate specificity
(data not shown). Thus, in the present study we used hLALP70 and
hLALP70v without any tag for the measurement of the enzyme activity.
Our results indicate that hLALP70v has a broad substrate specificity
with the ability of cleaving all nucleotide di- and triphosphates with
the exception of adenosine di- and triphosphate. In contrast to the
data published by Wang and Guidotti (10), hLALP70v did not prefer UDP
as optimal substrate. Rather, CTP was the preferred substrate, followed
by UDP and CDP. This difference might be due to a myc tag, which was
present in the construct used by Wang and Guidotti (10). This might
have implications in the substrate specificity, comparable with what we
observed for the GFP tag. Actually, Wang and Guidotti (10) did not
include CTP in their substrate list, and it is not evident whether they
used CTP as a substrate at all. Our results depending on hLALP70v
without any tag does not confirm that this enzyme is a UDPase.
hLALP70 exhibited a different substrate specificity compared with
hLALP70v. The preferred substrates were UTP and TTP, and all other
nucleotide di- and triphosphates were not or only to a much lesser
extent cleaved. This indicates that the 8 extra amino acids in LALP70
have a strong influence on the substrate specificity of this enzyme.
The investigation of other apyrases also revealed a strong dependence
of enzyme properties on minor sequence differences. Apyrase isoforms
(NTP1 and NTP3) encoded from two different genes in Toxoplasma
gondii had an amino acid sequence identity of 97% but differed
markedly in their substrate binding and specificity (4). This was
attributed to two 12-amino acid-long sequences, FITGREMLASID and
IVTGGGMLAAIN, which are located at the C terminus of these proteins,
where they constitute the region of highest dissimilarity between the
two isoforms. However, no similarity between our 8-amino acid sequence
and the two 12-amino acid sequences are obvious. Furthermore, a human brain ectoapyrase was used for site-directed mutagenesis of two conserved tryptophan residues (W187A, W459A; Ref. 5), which are also
conserved in hLALP70 (Trp227, Trp526; Ref. 11).
While the W187A mutation abrogated the enzymatic activity, a
stimulation of the NTPase activity was observed in case of the W459A
mutation. Other single amino acid mutations revealed similar results
(6). Finally, in addition to the changes in substrate specificity, the
hLALP70-specific motif VSFASSQQ has also an influence on the enzymatic
dependence on divalent ions like Ca2+ and
Mg2+.
hLALP70v, which has been described as a Golgi-resident protein (10), is
a homolog to the yeast intracellular apyrase GDA1, also located in the
Golgi apparatus. GDA1 functions as a GDPase, converting GDP to GMP,
which is then transported from the Golgi lumen into the cytosol in
exchange with a GDP activated sugar (9). Since GDP-activated sugars are
essential for protein glycosylation in the Golgi compartment, GDA1
mutants exhibit less glycosylated proteins and an increased level of
GDP in the Golgi cisternae (9). Recently, a mouse UDPase has been
cloned and characterized, which is localized in the endoplasmic
reticulum (ER-UDPase; Ref. 19). It is thought that the ER-UDPase can
unfold a similar function in the ER as GDA1 in the Golgi complex, being
critical in the reutilization of UDP during reglycosylation of
misfolded glycoproteins (20-22). ER-UDPase, which sequence is
unrelated to that of the hLALP proteins, is a soluble protein. In
contrast to hLALP70v and to the ER-UDPase, hLALP70 has been located in
autophagic/lysosomal vacuoles (11). It has to be elucidated by further
experiments, whether hLALP70 is also active in the reutilization of
NTPs/NDPs from the lysosomal/autophagic compartment, as has been
proposed earlier (11). In lysosomes only nucleoside transport systems have been described so far (23), and one can assume that NTPs and NDPs
trapped in a lysosomal vacuoles have to be degraded at least to NMPs,
in analogy to the Golgi compartment and the rough endoplasmic reticulum
(RER), to be transported into the cytosol. However, since the lysosomal
compartment does not provide a protein glycosylation machinery, it is
unlikely that the outward transport of monophosphate nucleotides or
nucleosides is linked to an inward transport of NDP-activated sugars,
as it has been described for the Golgi compartment (9) and the RER (21,
22).
Although most of a transiently expressed hLALP70/GFP fusion protein was
colocalized with lamp1-positive vacuoles, a further association with
the Golgi apparatus and the ER could not be ruled out (11).
Furthermore, the Golgi localization of hLALP70v has been shown only
indirectly (10), and it remains to be shown that this splice variant is
exclusively located in this compartment or might also occur in
lysosomes. Thus, the question remains open whether the amino acid motif
VSFASSQQ also contains sorting information.
 |
ACKNOWLEDGEMENTS |
We thank Melanie Hudler and Hartmut Engel for
expert technical assistance and Ralf Roesser for preparing the
electronic file of the manuscript.
 |
FOOTNOTES |
*
This work was partially supported by Deutsche
Forschungsgemeinschaft Grant EL125/1,2.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ246165.
§
Both authors participated equally in this study.
To whom correspondence should be addressed: Institut für
klinische Zytobiologie und Zytopathologie, Robert-Koch Str. 5, D-35033 Marburg, Germany. Tel.: 49-6421-2864075; Fax: 49-6421-2866414; E-mail:
elsaesse@mailer.uni-marburg.de.
Published, JBC Papers in Press, April 12, 2000, DOI 10.1074/jbc.M001245200
 |
ABBREVIATIONS |
The abbreviations used are:
ACR, apyrase
conserved region;
DAPI, 4,6-diamino-2-phenylindole;
hLALP70, human
lysosomal apyrase-like protein of 70 kDa;
mLALP, mouse lysosomal
apyrase-like protein;
hLALP70v, human variant of lysosomal apyrase-like
protein of 70 kDa;
mLALPv, mouse variant lysosomal apyrase-like
protein;
NTPase, triphosphate nucleotidase;
NTP, triphosphate
nucleotide;
NDP, diphosphonucleotide;
RT-PCR, reverse transcriptase
polymerase chain reaction;
FISH, fluorescence in situ
hybridization;
EST, expressed sequence tag;
GFP, green fluorescence
protein;
ER, endoplasmic reticulum;
RER, rough endoplasmic reticulum;
bp, base pair(s);
FITC, fluorescein isothiocyanate;
kb, kilobase pair(s).
 |
REFERENCES |
| 1.
|
Plesner, L.
(1995)
Int. Rev. Cytol.
158,
141-214
|
| 2.
|
Handa, M.,
and Guidotti, G.
(1996)
Biochem. Biophys. Res. Commun.
218,
916-923
|
| 3.
|
Bermudes, D.,
Peck, K. R.,
Afifi, M. A.,
Beckers, C. J. M.,
and Joiner, K. A.
(1994)
J. Biol. Chem.
269,
29252-29260
|
| 4.
|
Nakaar, V.,
Beckers, C. J.,
Polotsky, V.,
and Joiner, K. A.
(1998)
Mol. Biochem. Parasitol.
97,
209-220
|
| 5.
|
Smith, T. M.,
Lewis, C. S. A.,
and Kirley, T. L.
(1999)
Biochemistry
38,
5849-5857
|
| 6.
|
Smith, T. M.,
and Kirley, T. L.
(1998)
Biochim. Biophy. Acta
1386,
65-78
|
| 7.
|
Maliszewski, C. R.,
Delespesse, G. J. T.,
Schoenborn, M. A.,
Armitage, R. J.,
Fanslow, W. C.,
Nakajima, T.,
Baker, E.,
Sutherland, G. R.,
Poindexter, K.,
Birks, C.,
Alpert, A.,
Friend, D.,
Gimpel, S. D.,
and Gayle, R. B.
(1994)
J. Immunol.
153,
3574-3583
|
| 8.
|
Kegel, B.,
Braun, N.,
Heine, P.,
Maliszewski, C. R.,
and Zimmermann, H.
(1997)
Neuropharmacology
36,
1189-1200
|
| 9.
|
Abeijon, C.,
Yanagisawa, K.,
Mandon, E. C.,
Häusler, A.,
Moremen, K.,
Hirschberg, C. B.,
and Robbins, P. W.
(1993)
J. Cell Biol.
122,
307-323
|
| 10.
|
Wang, T. F.,
and Guidotti, G.
(1998)
J. Biol. Chem.
273,
11392-11399
|
| 11.
|
Biederbick, A.,
Rose, S.,
and Elsässer, H. P.
(1999)
J. Cell Sci.
112,
2473-2484
|
| 12.
|
Singer, J. S.
(1990)
Annu. Rev. Cell Biol.
6,
247-296
|
| 13.
|
Kunz, J.,
Scherer, S. W.,
Klawitz, I.,
Soder, S.,
Du, Y. Z.,
Speich, N.,
Kalff-Suske, M.,
Heng, H. H.,
Tsui, L. C.,
and Grzeschik, K. H.
(1994)
Genomics
22,
439-448
|
| 14.
|
Biederbick, A.,
Kern, H. F.,
and Elsässer, H. P.
(1995)
Eur. J. Cell Biol.
66,
3-14
|
| 15.
|
Ames, B. N.
(1966)
Methods Enzymol.
8,
115-117
|
| 16.
|
Lanzetta, P. A.,
Alvarez, L. J.,
Reinach, P. S.,
and Candia, O. A.
(1979)
Anal. Biochem.
100,
95-97
|
| 17.
|
Nagase, T.,
Ishikawa, K.,
Nakajima, D.,
Ohira, M.,
Seki, N.,
Miyajima, N.,
Tanaka, A.,
Kotani, H.,
Nomura, N.,
and Ohara, O.
(1997)
DNA Res.
4,
141-150
|
| 18.
|
Smith, T. M.,
and Kirley, T. L.
(1999)
Biochemistry
38,
321-328
|
| 19.
|
Trombetta, E. S.,
and Helenius, A.
(1999)
EMBO J.
18,
3282-3292
|
| 20.
|
Perez, M.,
and Hirschberg, C. B.
(1986)
J. Biol. Chem.
261,
6822-6830
|
| 21.
|
Vanstapel, F.,
and Blanckaert, N.
(1988)
J. Clin. Invest.
82,
1113-1122
|
| 22.
|
Helenius, A.,
Trombetta, E. S.,
Hebert, D.,
and Simons, J.
(1997)
Trends Cell Biol.
7,
193-199
|
| 23.
|
Pisoni, R. L.,
and Thoene, J. G.
(1991)
Biochim. Biophys. Acta
1071,
351-373
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Maoz, R. Koren, I. Ben-Ari, and T. Kleinberger
YND1 Interacts with CDC55 and Is a Novel Mediator of E4orf4-induced Toxicity
J. Biol. Chem.,
December 16, 2005;
280(50):
41270 - 41277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Faudry, S. P. Lozzi, J. M. Santana, M. D'Souza-Ault, S. Kieffer, C. R. Felix, C. A. O. Ricart, M. V. Sousa, T. Vernet, and A. R. L. Teixeira
Triatoma infestans Apyrases Belong to the 5'-Nucleotidase Family
J. Biol. Chem.,
May 7, 2004;
279(19):
19607 - 19613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. U. Failer, N. Braun, and H. Zimmermann
Cloning, Expression, and Functional Characterization of a Ca2+-dependent Endoplasmic Reticulum Nucleoside Diphosphatase
J. Biol. Chem.,
September 27, 2002;
277(40):
36978 - 36986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-D. Shi, T. Kukar, C.-Y. Wang, Q.-Z. Li, P. E. Cruz, A. Davoodi-Semiromi, P. Yang, Y. Gu, W. Lian, D. H. Wu, et al.
Molecular Cloning and Characterization of a Novel Mammalian Endo-apyrase (LALP1)
J. Biol. Chem.,
May 11, 2001;
276(20):
17474 - 17478.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.